| Gene symbol | PSCA | Synonyms | PRO232, lncPSCA | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q24.3 | dbXrefs | |
| Description | prostate stem cell antigen | ||||
| GTO ID | GTC3703 |
| Trial ID | NCT06193486 |
| Disease | Prostate Cancer |
| Altered gene | PSCA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MSGV1-PSCA-8T28Z |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Clinical Trial of an Infusion of Autologous Gamma Delta T Cells Genetically Engineered With a Chimeric Receptor to Target the Prostate Stem Cell Antigen in Patients With Metastatic Castration Resistant Prostate Cancer |
| Year | 2024 |
| Country | United States |
| Company sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Other ID(s) | MCC-22344 |
| Cohort 1 | |||||||||||||
|
|||||||||||||